Managing Complex Hepatocellular Carcinoma Subtypes: Diffuse Infiltrative, Large Tumours, and Tumour Rupture-The Challenges and Strategies [0.03%]
复杂肝细胞癌亚型的管理：弥漫性浸润、巨大肿瘤和肿瘤破裂——挑战与策略
Ashok Choudhury,Akash Roy,Amar Mukund et al.
Ashok Choudhury et al.
Hepatocellular carcinoma (HCC) is the sixth most common cause of cancer globally, third most common cause of cancer-related death, and most common primary liver malignancy. Whilst nodular well-defined HCC remains the classical phenotype, pr...
Naltrexone for Alcohol Use Disorder in Cirrhosis: Bridging the Gap in an Understudied Population [0.03%]
纳曲酮用于肝硬化的酒精使用障碍：在研究不足的人群中弥合差距
Romina Vergara-Quispe,David Marti-Aguado,Ramón Bataller
Romina Vergara-Quispe
Gut Microbiota and Genetic Polymorphisms Appear to Drive Disease Expression of Nonalcoholic Fatty Liver Disease in Lean Individuals [0.03%]
肠道菌群和基因多态性似乎是驱动非酒精性脂肪肝疾病在瘦人中发病的元凶
Prajna Anirvan,Zaiba H Khan,Pallavi Bhuyan et al.
Prajna Anirvan et al.
Background/objectives: There are very few comparative studies worldwide between 'lean' and 'nonlean/obese nonalcoholic fatty liver disease (NAFLD)' patients analyzing the differences in gut microbiome, genotype, and serum...
Statins in Metabolic Dysfunction-Associated Liver Disease: Hope, Hurdles, and Biostatistical Hazards [0.03%]
与代谢功能障碍相关的肝病中他汀类药物的应用：希望、挑战和生物统计学风险
Nina Kimer,Elliot B Tapper
Nina Kimer
Anil C Anand,James Neuberger
Anil C Anand
Comparative Study of Terlipressin and Noradrenaline as Vasopressors in Patients With Acute-on-chronic Liver Failure and Septic Shock: A Randomized Controlled Trial [0.03%]
急性肝衰竭和脓毒性休克患者中特利加压素与去甲肾上腺素作为升压药的对比研究：一项随机对照试验
Tarana Gupta,Anjali Saini,Vaibhav Gaur et al.
Tarana Gupta et al.
Background: Sepsis is the most common acute insult in patients with acute-on-chronic liver failure (ACLF), and circulatory failure portends a poor prognosis in them. ...
Portal Hypertension as the First Manifestation of Primary Amyloidosis [0.03%]
原发性淀粉样变性的第一个表现可能是门脉高压症
Shrey Bhatt,Venkatesh Vaithiyam,Ravi Teja Reddy et al.
Shrey Bhatt et al.
Comparison of Serological Immune Response to Hepatitis B Vaccine Following Rapid or Standard Regimen in People Who Inject Drugs [0.03%]
快速方案与标准方案对药物注射人群乙型肝炎疫苗血清免疫反应的比较研究
Nalinikanta Rajkumar,Ajay K Mishra,Lokeshwar Khumukcham et al.
Nalinikanta Rajkumar et al.
Background & aims: The standard regimen of hepatitis B vaccination, i.e., three doses at 0, 1, and 6 months, protects 90-95% of vaccine recipients. Compliance for three doses, administered over six months, is particularly...
Human Fascioliasis a Silent Menace: Case Report With Review of Literature [0.03%]
人类肝片形吸虫病一种隐匿的危害：病例报道及文献复习
Rohan Grotra,Rohan Malik,Ashwin Varadarajan et al.
Rohan Grotra et al.
Fascioliasis is a tropical zoonotic disease caused by liver flukes (Fasciola hepatica and Fasciola gigantica) mostly in sheep, goats, and cattle. It is a prevalent infection in developing countries like Bolivia, Peru, and Egypt, affecting b...
Prevalence and Clinical Correlation of Cardiometabolic Risk Factors in Alcohol-Related Liver Disease and Metabolic Dysfunction and Alcohol Associated Liver Disease (MetALD) [0.03%]
酒精性肝病和代谢异常及与饮酒相关肝病（MetALD）的 cardiometabolic危险因素的流行率及其临床意义
Wesley Dixon,Kathleen E Corey,Jay Luther et al.
Wesley Dixon et al.
Background: Recent introduction of new steatotic liver disease categorizations has necessitated updated epidemiologic studies. Specifically, recognition of (1) "MetALD" defined as where metabolic dysfunction-associated st...